INGESTEM: academic and industrial research partner

INGESTEM collaborates with many academic scientists and participates in consortia of European and international networks. Partnerships with biotech companies and the pharmaceutical industry have also been established.

The gathering of five academic centers, leaders on embryonic stem cells and induced pluripotent stem cell technologies, will enable biotech companies and pharma industry to accelerate the development of their projects in the field of personalized and regenerative medicine.

KEY BENEFITS:

• Access to complementary expertise of INGESTEM teams
• Interactions with key opinion leaders of the field
• Access to resources, up to date equipment and technologies
• Access to various patient cohorts and biobanks of ES cells, IPS cells and their differentiated progeny.